Pharmacokinetics, Pharmacodynamics, & Drug Metabolism Community

 View Only
Back to discussions
Expand all | Collapse all

Model-based approaches for drug development in Rare Diseases

  • 1.  Model-based approaches for drug development in Rare Diseases

    Community Leadership
    Posted 03-07-2024 20:10

    Can model-based approaches for rare diseases tackle the difficulties arising from the limited size of patient populations in clinical trials?

    Any experience, inputs and recommendation to share with the community?



    ------------------------------
    Pankajini Mallick PhD
    Principal Scientist, Preclinical Pharmacokinetics | DMPK
    San Diego CA


    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------